"","Year","Diagnoses/Case","Estimate","Min.","1st Qu.","Median","Mean","3rd Qu.","Max."
"1",2010,"PLWHA","PLWHA",NA,NA,NA,2189.7,NA,NA
"6",2010,"Base Case","Undiagnosed Cases",62.4,63.3,65.1,65.7,67.4,70.2
"26",2010,"Base Case","True Prevalence",2252.1,2253.1,2254.8,2255.4,2257.2,2259.9
"46",2010,"Base Case","Undiagnosed Fraction (%)",2.8,2.8,2.9,2.9,3,3.1
"7",2010,"Base Case using Stage","Undiagnosed Cases",13.4,14.1,17.2,17.7,20.8,23.1
"27",2010,"Base Case using Stage","True Prevalence",2203.1,2203.8,2206.9,2207.5,2210.6,2212.9
"47",2010,"Base Case using Stage","Undiagnosed Fraction (%)",0.6,0.6,0.8,0.8,0.9,1
"9",2010,"Upper Bound","Undiagnosed Cases",116.5,118.6,119.8,120.3,121.5,124.9
"29",2010,"Upper Bound","True Prevalence",2306.2,2308.3,2309.5,2310,2311.2,2314.6
"49",2010,"Upper Bound","Undiagnosed Fraction (%)",5.1,5.1,5.2,5.2,5.3,5.4
"8",2010,"Upper Bound using Stage","Undiagnosed Cases",22,22.2,25.7,27.7,31.2,37.2
"28",2010,"Upper Bound using Stage","True Prevalence",2211.8,2211.9,2215.5,2217.4,2221,2226.9
"48",2010,"Upper Bound using Stage","Undiagnosed Fraction (%)",1,1,1.2,1.2,1.4,1.7
"2",2011,"PLWHA","PLWHA",NA,NA,NA,2189.7,NA,NA
"10",2011,"Base Case","Undiagnosed Cases",66.9,67.6,68.4,68.8,69.7,71.5
"30",2011,"Base Case","True Prevalence",2256.6,2257.3,2258.1,2258.5,2259.4,2261.2
"50",2011,"Base Case","Undiagnosed Fraction (%)",3,3,3,3,3.1,3.2
"11",2011,"Base Case using Stage","Undiagnosed Cases",14.4,16.5,17.5,17,18.1,18.8
"31",2011,"Base Case using Stage","True Prevalence",2204,2206.1,2207.2,2206.7,2207.8,2208.5
"51",2011,"Base Case using Stage","Undiagnosed Fraction (%)",0.7,0.7,0.8,0.8,0.8,0.9
"12",2011,"Upper Bound","Undiagnosed Cases",126.6,126.6,127.3,128.8,129.5,134.2
"32",2011,"Upper Bound","True Prevalence",2316.3,2316.3,2317,2318.5,2319.2,2323.9
"52",2011,"Upper Bound","Undiagnosed Fraction (%)",5.5,5.5,5.5,5.6,5.6,5.8
"13",2011,"Upper Bound using Stage","Undiagnosed Cases",24.8,26.1,27.3,27.9,29.1,32
"33",2011,"Upper Bound using Stage","True Prevalence",2214.5,2215.8,2217,2217.6,2218.8,2221.7
"53",2011,"Upper Bound using Stage","Undiagnosed Fraction (%)",1.1,1.2,1.2,1.3,1.3,1.4
"3",2012,"PLWHA","PLWHA",NA,NA,NA,2218.2,NA,NA
"15",2012,"Base Case","Undiagnosed Cases",72.3,74.2,75.1,75,75.8,77.5
"35",2012,"Base Case","True Prevalence",2290.5,2292.4,2293.2,2293.1,2294,2295.7
"55",2012,"Base Case","Undiagnosed Fraction (%)",3.2,3.2,3.3,3.3,3.3,3.4
"16",2012,"Base Case using Stage","Undiagnosed Cases",17.9,19.1,20.1,20.3,21.3,23.3
"36",2012,"Base Case using Stage","True Prevalence",2236,2237.2,2238.2,2238.5,2239.5,2241.5
"56",2012,"Base Case using Stage","Undiagnosed Fraction (%)",0.8,0.9,0.9,0.9,1,1
"14",2012,"Upper Bound","Undiagnosed Cases",130.8,133.4,136.4,135.9,138.9,139.9
"34",2012,"Upper Bound","True Prevalence",2349,2351.6,2354.6,2354.1,2357.1,2358.1
"54",2012,"Upper Bound","Undiagnosed Fraction (%)",5.6,5.7,5.8,5.8,5.9,5.9
"17",2012,"Upper Bound using Stage","Undiagnosed Cases",29.3,30.9,32.2,33,34.4,38.4
"37",2012,"Upper Bound using Stage","True Prevalence",2247.5,2249,2250.4,2251.2,2252.6,2256.6
"57",2012,"Upper Bound using Stage","Undiagnosed Fraction (%)",1.3,1.4,1.4,1.5,1.5,1.7
"4",2013,"PLWHA","PLWHA",NA,NA,NA,2256.3,NA,NA
"20",2013,"Base Case","Undiagnosed Cases",57.1,59.7,63.3,64.1,67.7,72.7
"40",2013,"Base Case","True Prevalence",2313.4,2316,2319.6,2320.4,2324,2329
"60",2013,"Base Case","Undiagnosed Fraction (%)",2.5,2.6,2.7,2.8,2.9,3.1
"18",2013,"Base Case using Stage","Undiagnosed Cases",11,12.3,14.6,15.4,17.6,21.3
"38",2013,"Base Case using Stage","True Prevalence",2267.3,2268.6,2270.9,2271.7,2273.9,2277.6
"58",2013,"Base Case using Stage","Undiagnosed Fraction (%)",0.5,0.5,0.6,0.7,0.8,0.9
"19",2013,"Upper Bound","Undiagnosed Cases",101.7,106.5,111.9,113,118.4,126.4
"39",2013,"Upper Bound","True Prevalence",2358,2362.8,2368.2,2369.3,2374.7,2382.7
"59",2013,"Upper Bound","Undiagnosed Fraction (%)",4.3,4.5,4.7,4.8,5,5.3
"21",2013,"Upper Bound using Stage","Undiagnosed Cases",15.4,19.1,21.9,22.9,25.7,32.5
"41",2013,"Upper Bound using Stage","True Prevalence",2271.8,2275.4,2278.2,2279.2,2282,2288.8
"61",2013,"Upper Bound using Stage","Undiagnosed Fraction (%)",0.7,0.8,1,1,1.1,1.4
"5",2014,"PLWHA","PLWHA",NA,NA,NA,2306.2,NA,NA
"22",2014,"Base Case","Undiagnosed Cases",44.4,46.8,49.2,49,51.2,53.3
"42",2014,"Base Case","True Prevalence",2350.5,2352.9,2355.3,2355.1,2357.4,2359.5
"62",2014,"Base Case","Undiagnosed Fraction (%)",1.9,2,2.1,2.1,2.2,2.3
"23",2014,"Base Case using Stage","Undiagnosed Cases",3.4,5.9,8.3,7.4,9.4,10.5
"43",2014,"Base Case using Stage","True Prevalence",2309.5,2312,2314.5,2313.6,2315.6,2316.6
"63",2014,"Base Case using Stage","Undiagnosed Fraction (%)",0.1,0.3,0.4,0.3,0.4,0.5
"24",2014,"Upper Bound","Undiagnosed Cases",85.4,87.3,89.3,90.3,92.8,96.2
"44",2014,"Upper Bound","True Prevalence",2391.5,2393.5,2395.4,2396.5,2398.9,2402.4
"64",2014,"Upper Bound","Undiagnosed Fraction (%)",3.6,3.6,3.7,3.8,3.9,4
"25",2014,"Upper Bound using Stage","Undiagnosed Cases",6.9,8.1,9.3,11.4,13.7,18.1
"45",2014,"Upper Bound using Stage","True Prevalence",2313.1,2314.2,2315.4,2317.6,2319.8,2324.2
"65",2014,"Upper Bound using Stage","Undiagnosed Fraction (%)",0.3,0.3,0.4,0.5,0.6,0.8
